This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Harvard College, The Broad Institute, Inc., The General Hospital Corporation. Active years: 2023-2024.
Company Filing History:
1 out of 3,069 
1 out of 480 
1 out of 3,068 
Years Active: 2023-2024
Title: Innovations by Douglas Kenny: Pioneering Cholesterol-Reducing Technologies
Introduction
Douglas Kenny is an innovative inventor based in Cambridge, MA, USA. He holds two patents that focus on advancements in cholesterol-reducing compositions through the utilization of unique microbial engineering techniques. His work has made significant contributions to the field of biotechnology, particularly in addressing health issues related to cholesterol levels.
Latest Patents
Kenny's latest patents include pioneering research on cholesterol-reducing compositions and methods of use thereof, specifically through microbes expressing cholesterol oxidoreductase (COR) proteins. These patents detail methods for engineering microbes that express COR proteins, along with various compositions and applications using these engineered microbes. This innovative approach has the potential to transform how cholesterol levels are managed in medical and nutritional contexts.
Career Highlights
Throughout his career, Douglas Kenny has collaborated with esteemed institutions such as the Broad Institute, Inc. and The General Hospital Corporation. His roles at these institutions reflect his commitment to advancing scientific research and product development in the biotechnology sector. His endeavors have solidified his reputation as a significant contributor to innovations in health sciences.
Collaborations
In his pursuit of innovation, Kenny has worked alongside notable scientists, including Hera Vlamakis and Emily Patricia Balskus. These collaborations have likely enabled the sharing of ideas and resources, leading to groundbreaking advancements in microbiology and its applications in health.
Conclusion
Douglas Kenny's contributions to the field of biotechnology, particularly through his cholesterol-reducing innovations, underscore the importance of inventive minds in addressing global health challenges. His expertise in microbial applications illustrates the potential of scientific research to create impactful solutions for a healthier future. The ongoing developments from his patents are eagerly anticipated in the scientific community.